{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:40:30Z","timestamp":1777506030643,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"vor","delay-in-days":9000,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[1995]]},"DOI":"10.1254\/jjp.67.253","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T05:13:33Z","timestamp":1201151613000},"page":"253-258","source":"Crossref","is-referenced-by-count":41,"title":["Inhibitory Effect of Clopidogrel, Vapiprost and Argatroban on the Middle Cerebral Artery Thrombosis in the Rat"],"prefix":"10.1016","volume":"67","author":[{"given":"Kazuo","family":"Umemura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1254\/jjp.67.253_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0049-3848(87)90398-7","article-title":"Broad spectrum anti-platelet activity of ticlopidine and PCR-4099 involves the suppression of the effects of released ADP","volume":"48","author":"Feliste","year":"1987","journal-title":"Thromb Res"},{"key":"10.1254\/jjp.67.253_bib2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/bmj.296.6618.320","article-title":"Secondary prevention of vascular disease by prolonged antiplatelet treatment","volume":"296","year":"1988","journal-title":"Br Med J"},{"key":"10.1254\/jjp.67.253_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.STR.14.1.5","article-title":"\u201cAICLA\u201d controlled trial of aspirin and dipyridamole in the secondary prevention of arthero-thrombotic cerebral ischemia","volume":"14","author":"Bousser","year":"1983","journal-title":"Stroke"},{"key":"10.1254\/jjp.67.253_bib4","first-page":"53","article-title":"A randomized trial of aspirin and sulfinpyrazone in threatened stroke","volume":"229","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1254\/jjp.67.253_bib5","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/01.STR.23.6.912","article-title":"Role of ticlopidine for prevention of stroke","volume":"23","author":"Gregory","year":"1992","journal-title":"Stroke"},{"key":"10.1254\/jjp.67.253_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1212\/WNL.42.1.111","article-title":"Prevention of stroke with ticlopidine: Who benefits most?","volume":"42","author":"Grotta","year":"1992","journal-title":"Neurology"},{"key":"10.1254\/jjp.67.253_bib7","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1161\/01.STR.25.7.1469","article-title":"Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat: Effects of neutrophil depletion","volume":"25","author":"Matsuno","year":"1994","journal-title":"Stroke"},{"key":"10.1254\/jjp.67.253_bib8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.STR.24.7.1077","article-title":"Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model","volume":"24","author":"Umemura","year":"1993","journal-title":"Stroke"},{"key":"10.1254\/jjp.67.253_bib9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-0038-1646609","article-title":"The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion","volume":"61","author":"Hornby","year":"1989","journal-title":"Thromb Haemost"},{"issue":"Supp I","key":"10.1254\/jjp.67.253_bib10","first-page":"I-42","article-title":"Pathophysiological actions of thromboxane A2 and their pharmacological antagonism by thromboxane receptor blockade with GR32191","volume":"81","author":"Humphrey","year":"1990","journal-title":"Circulation"},{"key":"10.1254\/jjp.67.253_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0049-3848(87)90398-7","article-title":"Broad spectrum anti-platelet activity of ticlopidine and PCR-4099 involves the suppression of the effects of released ADP","volume":"48","author":"Feliste","year":"1987","journal-title":"Thromb Res"},{"key":"10.1254\/jjp.67.253_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/01.RES.70.1.39","article-title":"ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries","volume":"70","author":"Yao","year":"1992","journal-title":"Circ Res"},{"key":"10.1254\/jjp.67.253_bib13","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1055\/s-0038-1646307","article-title":"Comparative arterial antithrombotic activity of clopidogrel and acetyl salicylic acid in the pig","volume":"68","author":"Samama","year":"1992","journal-title":"Thromb Haemostas"},{"key":"10.1254\/jjp.67.253_bib14","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1055\/s-0038-1656376","article-title":"Synergistic antithrombotic properties of G4120, a RGD-containing synthetic peptide, and argatroban, a synthetic thrombin inhibitor, in a hamster femoral vein platelet-rich thrombosis model","volume":"68","author":"Imura","year":"1992","journal-title":"Thromb Haemostas"},{"key":"10.1254\/jjp.67.253_bib15","first-page":"895","article-title":"Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis model","volume":"261","author":"Imura","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.67.253_bib16","first-page":"1426","article-title":"Thrombin-catalyzed activation of a single chain bovine factor V","volume":"254","author":"Neshheim","year":"1979","journal-title":"J Biol Chem"},{"issue":"Supp","key":"10.1254\/jjp.67.253_bib17","first-page":"II","article-title":"Importance of thrombin synthesis in mural thrombosis on collagen-coated glass","volume":"78","author":"Wagner","year":"1988","journal-title":"Circulation"},{"key":"10.1254\/jjp.67.253_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1172\/JCI114138","article-title":"Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury","volume":"84","author":"Edit","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1254\/jjp.67.253_bib19","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/01.CIR.82.4.1476","article-title":"Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis","volume":"82","author":"Heras","year":"1990","journal-title":"Circulation"},{"key":"10.1254\/jjp.67.253_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/01.CIR.81.1.219","article-title":"Prevention of platelet-rich arterial thrombosis by selective thrombin inhibitor","volume":"81","author":"Jang","year":"1990","journal-title":"Circulation"},{"key":"10.1254\/jjp.67.253_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0049-3848(83)90082-8","article-title":"Arachidonate induced aggregation of rat platelets may not require prostaglandin endoperoxides or thromboxane A2","volume":"30","author":"Nishizawa","year":"1983","journal-title":"Thromb Res"},{"key":"10.1254\/jjp.67.253_bib22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1476-5381.1992.tb14370.x","article-title":"Effects of vapiprost, a novel thromboxane receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tissue-type plasminogen activator","volume":"106","author":"Matsuno","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1254\/jjp.67.253_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/bi00368a019","article-title":"Thrombin generation and inactivation in the presence of anti-thrombin III and heparin","volume":"25","author":"Lindhout","year":"1986","journal-title":"Biochemistry"},{"key":"10.1254\/jjp.67.253_bib24","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1073\/pnas.85.9.3184","article-title":"Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone","volume":"85","author":"Hanson","year":"1988","journal-title":"Proc Natl Acad USA"},{"key":"10.1254\/jjp.67.253_bib25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1172\/JCI109661","article-title":"Effect of heparin and heparin fraction platelet aggregation","volume":"65","author":"Salzman","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1254\/jjp.67.253_bib26","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1073\/pnas.86.10.3619","article-title":"Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III. Implications for heparin efficacy","volume":"86","author":"Hogg","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1254\/jjp.67.253_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/blood.V53.1.47.47","article-title":"Antiheparin proteins secreted by human platelets. Purification, characterization, and radioimmunoassay","volume":"53","author":"Rucinski","year":"1979","journal-title":"Blood"}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819355957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819355957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T23:19:47Z","timestamp":1605655187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021519819355957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995]]}},"alternative-id":["S0021519819355957"],"URL":"https:\/\/doi.org\/10.1254\/jjp.67.253","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[1995]]}}}